More than 70 years after insulin was found to be a treatment for diabetes, doctors still are trying to figure out a better way to get the hormone into the bodies of people who need it -- one that ...

A particularly unpleasant side effect of diabetes, especially if you’re squeamish, is having to inject yourself with insulin on a daily basis. Being able to administer insulin in an easier way, like ...

VIRGINIA BEACH, Va. (WVEC) -- No needles, no pricks, no pumps. Many people may not have heard about the form of insulin that prevents the discomfort or pain often associated with taking the ...

As many as one in four Americans are afraid of needles. That's led a handful of start-ups to develop alternatives to hypodermic syringes. This would be good news for health care: While needles provide ...

Needles aren’t popular. For people with type 1 diabetes (and some with type 2 diabetes) that can be a problem, since treatment requires regular injections with insulin. Now, researchers at MIT have ...

Researchers from Italy have created a robot that could one day allow diabetes patients to get a dose of insulin without any needles. PILLSID involves two separate parts. One component is an internal ...

Millions of people who have diabetes rely on insulin shots. Now, some are switching to insulin you can inhale. One man The NOW spoke with says it has changed his routine. Greg Straub says it feels ...

CINCINNATI (WKRC) - Thousands of children living with diabetes may soon have a new treatment option that eliminates the need for needles. Jacob, an 11-year-old football fan who has been living with ...

After obtaining a more detailed history, it was discovered that the patient had been reusing insulin needles and was not rotating sites for insulin injection. Insulin needle reuse could potentially ...

Imagine a device that lets people with diabetes use an app or remote control to give themselves a boost of insulin when they need it, without an injection. Researchers from ETH Zurich have developed a ...

The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...